NCT05009069 2026-01-22
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
Hoffmann-La Roche
Phase 2 Active not recruiting
Clinical Trials
9 trialsNCT04607421 2025-08-14
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
Phase 3 Active not recruiting
NCT02465593 2022-01-11
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer
PharmaEngine
Phase 1/2 Terminated
NCT03152370 2021-10-04
PRAER 1
Adlai Nortye Biopharma Co., Ltd.
Phase 1 Completed
NCT02694718 2017-01-11
A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer
Hoffmann-La Roche
Phase 2 Completed
NCT00022698 2016-04-15
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 2 Completed
NCT00421824 2011-01-04
Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer
Sanofi
Phase 2 Completed
NCT00174616 2009-12-07
CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision
Sanofi
Phase 2 Completed
NCT00263029 2009-09-18
PROCTFUL
Sanofi
Phase 2 Completed